Avalanche Australia Pty Ltd.
2Patents
2Active
2Granted
43Portfolio score
Filing activity: May 19, 2014 → Dec 21, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10004788B2 | Treatment of ocular neovascularization using anti-VEGF proteins | Chemistry; Metallurgy | 12 | Active |
| US9943573B2 | Treatment of ocular neovascularization using anti-VEGF proteins | Chemistry; Metallurgy | 12 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.